ArticleScientific reports2024
Amputated life-testing based on extended Dagum percentiles for type of group inspection plans: optimal sample sizes, termination time ratios analysis.
Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This paper introduces a novel approach to life-testing using Extended Dagum (EXD) percentiles within the framework of group inspection plans. The methodology focuses on optimizing sample sizes and analyzing termination time ratios to enhance the reliability of quality control procedures. By leveraging the flexibility of the EXD distribution, the proposed approach accurately models complex survival data, accommodating heavy-tailed characteristics often encountered in practice. The study presents a detailed analysis of optimal sample sizes and the critical termination time ratios that balance producer and consumer risks. Through comprehensive simulations and real applications, the paper demonstrates the effectiveness of the proposed methodology in ensuring robust and efficient life-testing strategies, offering valuable insights for practitioners in industries such as manufacturing, engineering, and reliability analysis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.